
Fennec Pharmaceuticals Inc.
FENCHealthcare|Biotechnology|US
$9.81
+0.42 (+4.47%)
Tangible Book / Share
$1.23
Cash / Share
$1.19
Next Earnings Report
Nov 12, 2026
EPS est. $0.10 · Revenue est. $18.9M
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Nov 18, 2025 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Apr 2028
Est. completion
P1P2Solid Tumor Malignancies
Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
NCT07407582n=25
Recent Press Releases
Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026
Nov 6, 2026 · GlobeNewsWire
SEC Filings (51)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 19, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Sep 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 13, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jun 11, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jun 10, 2026 | 8-K | Material event | DocumentIndex |
| May 22, 2026 | 8-K | Material event | DocumentIndex |
| May 18, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Apr 28, 2026 | 8-K | Material event | DocumentIndex |
| Apr 28, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Apr 28, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 22, 2026 | 8-K | Material event | DocumentIndex |
| Apr 7, 2026 | 8-K | Material event | DocumentIndex |
| Mar 27, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 24, 2026 | 8-K | Material event | DocumentIndex |
| Mar 16, 2026 | 8-K | Material event | DocumentIndex |
| Mar 5, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 4, 2026 | 8-K | Material event | DocumentIndex |
| Feb 20, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 11, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 9, 2025 | 8-K | Material event | DocumentIndex |
| Dec 2, 2025 | 8-K | Material event | DocumentIndex |
| Nov 19, 2025 | 8-K | Material event | DocumentIndex |
| Nov 18, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Nov 18, 2025 | 8-K | Material event | DocumentIndex |
| Nov 18, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 17, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 17, 2025 | 8-K | Material event | DocumentIndex |
| Nov 13, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Nov 13, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Nov 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jun 3, 2025 | 8-K | Material event | DocumentIndex |